IEX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/18/2026 15:59
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeIEX
Market Capitalization735.91 mln
Float32.84 mln
Earnings Date08/06/2026
EPS
1.66
Decent
P / E
10.36
Fair value
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-2.72
Likely reliable
1-Year Forecast
23.33
Strong upside
Relative Strength
3
/ 100
Severely lagging
Business Description
Amphastar Pharmaceuticals is a drug company based in Rancho Cucamonga, California, that develops and sells a broad range of medicines across the United States, China, and France. Its products cover several medical needs, including emergency treatments for severe low blood sugar and opioid overdose, respiratory relief for asthma and lung disease, and solutions for conditions such as iron deficiency, osteoporosis, and abnormal immune responses. The company produces both branded and generic medicines in injectable, inhaled, and nasal spray forms, as well as the raw pharmaceutical ingredients used to make insulin. Founded in 1996, Amphastar serves patients requiring both routine and urgent medical care.